Drug name - Amrix
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7829121 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US9375410 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US9399025 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US8877245 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US7544372 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US7820203 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US7790199 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Nov, 2023
(1 year, 1 month from now) | |
| US7387793 | TEVA PHARMS INTL | Modified release dosage forms of skeletal muscle relaxants |
Feb, 2025
(2 years from now) | |
Drugs and Companies using CYCLOBENZAPRINE HYDROCHLORIDE ingredient
Treatment: Relief of muscle spasm
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 15MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| 30MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.